Literature DB >> 22704946

Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage.

Wei Sun1, Amanda Peacock, Jane Becker, Barbara Phillips-Bute, Daniel T Laskowitz, Michael L James.   

Abstract

Intracerebral hemorrhage (ICH) is a devastating and common admitting diagnosis to intensive care units in the USA. Despite advances in critical care, patients with ICH often experience early neurological deterioration (END) in the first 72 hours after admission due to a variety of factors, including hematoma and cerebral edema evolution. The purpose of this study was to determine factors associated with END after ICH. Using the Duke University Hospital Neuroscience Critical Care Unit Database, we retrospectively identified patients with an admitting diagnosis of supratentorial ICH from January to December 2010, verified by CT imaging. END was defined as a decrease in the Glasgow Coma Scale score of ≥3 or death within the first 72 hours after hemorrhage. The chi-squared or t-test analysis was used to compare the groups, as appropriate. Multiple logistical regression modeling was performed to test for associations between likely predictors of END. Of the 89 subjects admitted with supratentorial ICH, we included 83 in the analysis based on complete datasets. Of these, 31 experienced END within 72 hours after onset of symptoms. ICH score, presence of midline shift on imaging, and white blood cell (WBC) count were used in a regression model for predicting END. WBC count demonstrated the greatest association with END. Patients with ICH are prone to END within the first few days after hemorrhage. Elevated WBC count appears predictive of deterioration. These data demonstrate that heightened inflammatory state after ICH may be related to early deterioration after injury.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22704946      PMCID: PMC3706635          DOI: 10.1016/j.jocn.2011.11.020

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  27 in total

Review 1.  A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology.

Authors:  Yahia Z Al-Tamimi; Nicolas M Orsi; Audrey C Quinn; Shervanthi Homer-Vanniasinkam; Stuart A Ross
Journal:  World Neurosurg       Date:  2010-06       Impact factor: 2.104

2.  Treatment of intracerebral hemorrhage in animal models: meta-analysis.

Authors:  Joseph Frantzias; Emily S Sena; Malcolm R Macleod; Rustam Al-Shahi Salman
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

3.  Early neurological change in patients with spontaneous supratentorial intracerebral hemorrhage.

Authors:  Takatoshi Sorimachi; Yukihiko Fujii
Journal:  J Clin Neurosci       Date:  2010-08-09       Impact factor: 1.961

4.  Spontaneous intracerebral hemorrhage with ventricular extension and the grading of obstructive hydrocephalus: the prediction of outcome of a special life-threatening entity.

Authors:  Marco Stein; Markus Luecke; Matthias Preuss; Dieter-Karsten Boeker; Andreas Joedicke; Matthias F Oertel
Journal:  Neurosurgery       Date:  2010-11       Impact factor: 4.654

5.  Imaging of leukocytic infiltration in human cerebral infarcts.

Authors:  C Pozzilli; G L Lenzi; C Argentino; A Carolei; M Rasura; A Signore; L Bozzao; P Pozzilli
Journal:  Stroke       Date:  1985 Mar-Apr       Impact factor: 7.914

6.  Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage.

Authors:  Michael L James; Patrick M Sullivan; Christopher D Lascola; Michael P Vitek; Daniel T Laskowitz
Journal:  Stroke       Date:  2008-12-24       Impact factor: 7.914

7.  Risk stratification for predicting 30-day mortality of intracerebral hemorrhage.

Authors:  Ya-Ching Chuang; Yung-Ming Chen; Shih-Kuei Peng; Shih-Yen Peng
Journal:  Int J Qual Health Care       Date:  2009-10-14       Impact factor: 2.038

8.  S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage.

Authors:  Michael L James; Robert Blessing; Barbara G Phillips-Bute; Ellen Bennett; Daniel T Laskowitz
Journal:  Biomarkers       Date:  2009-09       Impact factor: 2.658

9.  Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage.

Authors:  Jennifer Jaffe; Lora AlKhawam; Hongyan Du; Kristen Tobin; Judith O'Leary; Glen Pollock; H Hunt Batjer; Issam A Awad
Journal:  Neurosurgery       Date:  2009-03       Impact factor: 4.654

10.  Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage.

Authors:  Raymond Tak Fai Cheung; Liang-Yu Zou
Journal:  Stroke       Date:  2003-06-12       Impact factor: 7.914

View more
  20 in total

1.  Leukocyte Count and Intracerebral Hemorrhage Expansion.

Authors:  Andrea Morotti; Chia-Ling Phuah; Christopher D Anderson; Michael J Jessel; Kristin Schwab; Alison M Ayres; Alessandro Pezzini; Alessandro Padovani; M Edip Gurol; Anand Viswanathan; Steven M Greenberg; Joshua N Goldstein; Jonathan Rosand
Journal:  Stroke       Date:  2016-04-21       Impact factor: 7.914

2.  Peripheral monocyte count is associated with case fatality after intracerebral hemorrhage.

Authors:  Opeolu Adeoye; Kyle Walsh; Jessica G Woo; Mary Haverbusch; Charles J Moomaw; Joseph P Broderick; Brett M Kissela; Dawn Kleindorfer; Matthew L Flaherty; Daniel Woo
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-10-08       Impact factor: 2.136

3.  Inflammatory Biomarkers and Their Value in Predicting Survival and Outcome among Patients with Spontaneous Intracerebral Haemorrhage.

Authors:  Senthil Kumar Rajapathy; Zamzuri Idris; Regunath Kandasamy; Albert Wong Sii Hieng; Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2017-06-30

4.  Monocyte Count and 30-Day Case Fatality in Intracerebral Hemorrhage.

Authors:  Kyle B Walsh; Padmini Sekar; Carl D Langefeld; Charles J Moomaw; Mitchell S V Elkind; Amelia K Boehme; Michael L James; Jennifer Osborne; Kevin N Sheth; Daniel Woo; Opeolu Adeoye
Journal:  Stroke       Date:  2015-06-30       Impact factor: 7.914

Review 5.  An update on inflammation in the acute phase of intracerebral hemorrhage.

Authors:  Sheng Chen; Qingwu Yang; Gang Chen; John H Zhang
Journal:  Transl Stroke Res       Date:  2014-12-23       Impact factor: 6.829

6.  Admission Leukocytosis in Intracerebral Hemorrhage: Associated Factors and Prognostic Implications.

Authors:  Réza Behrouz; Shaheryar Hafeez; Chad M Miller
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

7.  Predictors of late neurological deterioration after spontaneous intracerebral hemorrhage.

Authors:  Weiping Sun; Wenqin Pan; Peter G Kranz; Claire E Hailey; Rachel A Williamson; Wei Sun; Daniel T Laskowitz; Michael L James
Journal:  Neurocrit Care       Date:  2013-12       Impact factor: 3.210

Review 8.  Monitoring inflammation (including fever) in acute brain injury.

Authors:  J Javier Provencio; Neeraj Badjatia
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

9.  Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage.

Authors:  Beilei Lei; Hana N Dawson; Briana Roulhac-Wilson; Haichen Wang; Daniel T Laskowitz; Michael L James
Journal:  J Neuroinflammation       Date:  2013-08-20       Impact factor: 8.322

Review 10.  Progressing haemorrhagic stroke: categories, causes, mechanisms and managements.

Authors:  Shiyu Chen; Liuwang Zeng; Zhiping Hu
Journal:  J Neurol       Date:  2014-03-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.